全球数位病理系统市场

到 2030 年，全球数位病理系统市场规模将达到 22 亿美元

全球数位病理系统市场规模预计在2024年为10亿美元，预计到2030年将达到22亿美元，2024年至2030年的复合年增长率为12.8%。报告分析的细分市场之一——设备市场——预计复合年增长率为12.7%，到分析期结束时规模将达到11亿美元。软体市场在分析期间内的复合年增长率预计为13.4%。

美国市场规模估计为 4.715 亿美元，中国市场预计复合年增长率为 13.8%

美国数位病理系统市场规模预计2024年达到4.715亿美元。作为世界第二大经济体，中国市场规模预计在2030年达到1.779亿美元，在2024-2030年的分析期间内，复合年增长率将达到13.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为9.9%和11.5%。在欧洲，预计德国市场的复合年增长率将达到11.5%。

全球数位病理系统市场—主要趋势与驱动因素摘要

什么是数位病理系统？它们如何彻底改变医疗保健？

数位病理系统代表了医学诊断领域的变革，它整合了数位成像、自动分析和先进的网路技术，以促进和增强对生物组织的检查。这些系统将玻璃载玻片转换成可以在电脑显示器上检视、管理和分析的数位载玻片。随着人工智慧和机器学习的整合，数位病理已成为加速诊断过程、提高准确性和支持病理学家决策流程的关键。该技术不仅简化了病理实验室的工作流程，而且还实现了远端会诊，从而改善了不同地理位置的专家诊断和协作。事实证明，这在多位专家的意见有益的复杂病例中特别有用，从而改善了全球患者的治疗效果和护理标准。

科技将如何提升数位病理系统的能力？

技术进步是数位病理学的核心，影像撷取、处理和分析技术的不断改进推动着该领域的发展。这些系统中使用的高解析度扫描器可以产生高度精细的影像，从而实现精确而全面的组织分析。基于人工智慧演算法的影像分析软体可以检测出人工检查中可能被忽视的模式和异常，从而减少错误并提高诊断信心。此外，云端处理的整合使得储存和共用大型影像檔案变得更加容易，使世界各地的病理学家能够即时协作。这种能力对于致力于开发新治疗方法和了解复杂疾病的教育机构和研究团队至关重要。此外，数据分析的进步有助于挖掘大量诊断数据，从而获得新的见解并改善个人化医疗策略。

数位病理系统将如何影响临床实践和研究？

数位病理系统的引入对临床实践和医学研究都产生了重大影响。在临床方面，它透过减少切片製备和检查所需的时间来提高病理科室的效率；这对于及时的患者管理和护理至关重要，尤其是在癌症等危重病例中。在研究方面，数位病理学可以对组织样本进行随时间推移的详细分析，从而促进对了解病情进展和治疗效果至关重要的纵向研究。此外，数位病理学提供的定量数据支持更客观、可重复的观察，从而提高研究结果的品质和可靠性。透过支援数位切片的存储，这些系统还可以保存宝贵的医疗数据，这些数据可用于教育目的和未来研究，从而创建不断增强的数据资源。

推动数位病理学市场成长的因素是什么？

数位病理学市场的成长受到多种因素的推动，包括技术创新、慢性病盛行率的上升以及对更高效诊断技术日益增长的需求。随着全球医疗保健系统持续面临越来越多的慢性病带来的压力，对更快、更准确的诊断方法的需求也日益迫切。数位病理学系统能够透过提高病理诊断服务的速度和准确性来满足这种需求。此外，人工智慧和机器学习技术的整合将在改进这些系统、提高其性能和效率方面发挥关键作用，从而促进其应用。不断变化的医疗法规支援在临床诊断中使用数位系统，这也促进了市场的成长。此外，文化向精准医疗和个人化治疗方案的转变，促使人们越来越依赖包括数位病理学诊断在内的先进诊断技术，以获得对个别疾病状态和治疗反应的详细洞察。这些技术、人口和监管因素共同推动数位病理学市场的扩张，确保其在未来医疗诊断领域发挥关键作用。

部分

细分市场（设备、软体、其他）、类型（人体病理学、兽医病理学）、最终用户（製药和生物技术公司、医院和参考实验室、学术和研究机构）

受访公司范例

• Danaher Corporation
• Cerner Corporation
• Barco NV
• Nikon Corporation
• Nikon Instruments, Inc.
• Koninklijke Philips NV
• A. Menarini Diagnostics Srl
• Leica Biosystems Nussloch GmbH
• MD Biosciences, Inc.
• Euromex Microscopen BV
• Apollo Enterprise Imaging Corporation
• Indica Labs, Inc.
• Inspirata, Inc.
• Mikroscan Technologies, Inc.
• Leica Mikrosysteme Vertrieb GmbH Mikroskopie und Histologie

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Digital Pathology Systems Market to Reach US$2.2 Billion by 2030

The global market for Digital Pathology Systems estimated at US$1.0 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 12.8% over the analysis period 2024-2030. Device, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Software segment is estimated at 13.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$471.5 Million While China is Forecast to Grow at 13.8% CAGR

The Digital Pathology Systems market in the U.S. is estimated at US$471.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$177.9 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.9% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.5% CAGR.

Global Digital Pathology Systems Market - Key Trends & Drivers Summarized

What Are Digital Pathology Systems and How Are They Revolutionizing Healthcare?

Digital pathology systems represent a transformative leap in the field of medical diagnostics, integrating digital imaging, automated analysis, and advanced networking to facilitate and enhance the examination of biological tissues. These systems convert glass slides into digital slides that can be viewed, managed, and analyzed on a computer monitor. With the integration of artificial intelligence and machine learning, digital pathology has become pivotal in accelerating diagnostic processes, increasing accuracy, and supporting pathologists in decision-making processes. The technology not only streamlines workflows in pathology labs but also enables remote consultations, thus improving access to expert diagnoses and collaboration across different geographical locations. This has proven particularly valuable in complex cases where multiple expert opinions are beneficial, thereby enhancing patient outcomes and care standards globally.

How Does Technology Advance the Capabilities of Digital Pathology Systems?

Technological advancements are at the core of digital pathology, with continuous improvements in image acquisition, processing, and analysis driving the field forward. High-resolution scanners used in these systems can produce extremely detailed images that allow for precise and comprehensive tissue analysis. Image analysis software equipped with AI algorithms can detect patterns and anomalies that might be missed in manual examinations, thus reducing errors and increasing the reliability of diagnoses. Furthermore, the integration of cloud computing has facilitated the storage and sharing of large image files, enabling real-time collaboration among pathologists around the world. This capability is critical in educational settings and among research teams working to develop new treatments and understand complex diseases better. Additionally, advancements in data analytics help in mining vast amounts of diagnostic data, which can lead to new insights and improvements in personalized medicine strategies.

What Impact Do Digital Pathology Systems Have on Clinical Practices and Research?

The implementation of digital pathology systems has profoundly impacted both clinical practices and medical research. Clinically, these systems have enhanced the efficiency of pathology departments by reducing the time needed for slide preparation and examination. They enable faster turnaround times for test results, which is crucial for timely patient management and care, especially in critical cases such as cancer. In research, digital pathology allows for the detailed analysis of tissue samples over extended periods, facilitating longitudinal studies that are essential for understanding disease progression and treatment effects. Additionally, the quantitative data provided by digital pathology supports more objective and reproducible findings, thus improving the quality and reliability of research outputs. By allowing the storage of digital slides, these systems also preserve valuable medical data, which can be used for educational purposes or future research, creating a continuously enriching data resource.

What Drives the Growth of the Digital Pathology Market?

The growth in the digital pathology market is driven by several factors, including technological innovations, the increasing incidence of chronic diseases, and the growing need for more efficient diagnostic techniques. As health systems around the world continue to face pressures from rising chronic disease rates, the demand for faster, more accurate diagnostic methods becomes more critical. Digital pathology systems offer the capability to meet these demands by enhancing the speed and accuracy of pathology services. Additionally, the integration of AI and machine learning technologies plays a significant role in advancing these systems, making them more capable and efficient, which in turn fuels their adoption. Changes in healthcare regulations that support the use of digital systems in clinical diagnostics also contribute to market growth. Furthermore, the cultural shift towards precision medicine and personalized treatment plans increases reliance on advanced diagnostic methods, including digital pathology, to obtain detailed insights into individual disease states and treatment responses. These technological, demographic, and regulatory factors collectively drive the expansion of the digital pathology market, ensuring its significant role in the future of healthcare diagnostics.

SCOPE OF STUDY:

The report analyzes the Digital Pathology Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Device, Software, Other Segments); Type (Human Pathology, Veterinary Pathology); End-Use (Pharma & Biotech Companies, Hospitals & Reference Labs, Academic & Research Institutes)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 74 Featured) -

• Danaher Corporation
• Cerner Corporation
• Barco NV
• Nikon Corporation
• Nikon Instruments, Inc.
• Koninklijke Philips N.V.
• A. Menarini Diagnostics Srl
• Leica Biosystems Nussloch GmbH
• MD Biosciences, Inc.
• Euromex Microscopen BV
• Apollo Enterprise Imaging Corporation
• Indica Labs, Inc.
• Inspirata, Inc.
• Mikroscan Technologies, Inc.
• Leica Mikrosysteme Vertrieb GmbH Mikroskopie und Histologie

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Digital Pathology Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • Digital Pathology: An Introduction
  • Key Digital Pathology Tools
  • Market Outlook
  • US and Europe Maintain Dominance
  • Emerging Markets to Experience Strong Growth
  • Scanners Lead Digital Pathology Market
  • Software Segment Post Strong Growth
  • Disease Diagnosis: Major Application of Digital Pathology Systems
  • Telepathology Experiences Strong Growth
  • Pharmaceutical and Biotechnology Companies: Important End Use Markets for Digital Pathology
  • Major Issues Hampering Adoption of Digital Pathology Systems
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Technological Advancements Drive Adoption of Digital Pathology Systems
  • Artificial Intelligence (AI) Steps in to Widen the Scope & Span of Digital Pathology
  • EXIBIT: AI Spending in Healthcare & Lifesciences in US$ Million for Years 2020 & 2025
  • Advantages of AI-Powered Digital Pathology
  • Digital Pathology Benefits Drug Discovery Process
  • Need for Early Diagnosis Puts Focus on Digital Pathology
  • Digital Pathology Systems See Fast Paced Adoption in Cancer and Other Chronic Diseases
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Digital Pathology Emerges as a Tool to Reduce Cases of Cancer Misdiagnoses
  • Scarcity of Pathologists & Excess Workload on Pathology Labs Drives Demand for Digital Systems
  • Clinical Research Continues to be Core Vertical for Digital Pathology
  • Digital Imaging and Robotic Light Microscopy Boost Growth
  • Computational Pathology for Leading-Edge Image Analytics
  • Cloud Platform Gains Momentum
  • Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
  • Rise in Significance of Personalized Medicine Bodes Well for Digital Pathology
  • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
  • Increased Focus on Companion Diagnostics to Benefit Market Growth
  • Improving Healthcare & Research Expenditure to Support Growth
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2024
  • Aging Population: A Key Opportunity Indicator
  • Global Aging Population: Population of 65+ Individuals (in Thousands) by Region for 2019 and 2030
  • Global Population of 65+ Individuals as % of Total Population by Region for 2019 and 2030
  • Challenges Facing Digital Pathology Systems Market
  • High Costs
  • Workflow Integration with Other Related Functions
  • Other Issues
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Digital Pathology Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Device by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Other Segments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Other Segments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Human Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Human Pathology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Veterinary Pathology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Veterinary Pathology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Hospitals & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Hospitals & Reference Labs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Digital Pathology Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • Market Overview
  • Increasing Pressure on Pathological Labs: Cornerstone for Growth
  • TABLE 29: USA Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• JAPAN
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • Market Overview
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• CHINA
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • Market Overview
  • TABLE 56: China Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• EUROPE
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • Market Overview
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• FRANCE
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• GERMANY
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Spain 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Russia 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • Market Overview
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Digital Pathology Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Australia 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• INDIA
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • Market Overview
  • Inadequate Infrastructure Impedes Adoption of Telepathology
  • TABLE 161: India Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Digital Pathology Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Latin America 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Argentina 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Brazil 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Mexico 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Digital Pathology Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Middle East 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Iran 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Israel 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: UAE 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030
• AFRICA
  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Digital Pathology Systems by Segment - Device, Software and Other Segments - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Digital Pathology Systems by Segment - Device, Software and Other Segments Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Africa 15-Year Perspective for Digital Pathology Systems by Segment - Percentage Breakdown of Value Revenues for Device, Software and Other Segments for the Years 2015, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Digital Pathology Systems by Type - Human Pathology and Veterinary Pathology Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Digital Pathology Systems by Type - Percentage Breakdown of Value Revenues for Human Pathology and Veterinary Pathology for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Digital Pathology Systems by End-Use - Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Digital Pathology Systems by End-Use - Percentage Breakdown of Value Revenues for Pharma & Biotech Companies, Hospitals & Reference Labs and Academic & Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION